doi:10.3969/j.issn.1004-583X.2025.12.013

Abstract

CLC Number:

R541

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2025.12.013

https://www.lchc.cn/EN/Y2025/V40/I12/1124

References 55

[1]	中华医学会心血管病学分会, 中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志, 2023, 51(6):572-618.
[2]	Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China[J]. J Epidemiol, 2008, 18(5):209-216. doi: 10.2188/jea.je2008021. pmid: 18776706
[3]	刘铎, 李燕玲, 张展, 等. 非瓣膜性心房颤动左心耳血栓的影像学研究进展[J]. 中华老年多器官疾病杂志, 2024, 23(7):545-548.
[4]	郑茜王敏, 冉海涛, 苏蕾. 超声心动图评价心房颤动患者左心耳形态结构和功能的研究进展[J]. 中国医学影像学杂志, 2023, 31(7):795-798.
[5]	Sun Y, Ling Y, Chen Z, et al. Finding low CHA2DS2-VASc scores unreliable? Why not give morphological and hemodynamic methods a try?[J]. Front Cardiovasc Med, 2023, 9:1032736. doi: 10.3389/fcvm.2022.1032736.
[6]	李雯琳, 张志. 心房颤动患者左心耳形态结构和功能与左心耳血栓及心源性卒中的关系研究进展[J]. 临床荟萃, 2024, 39(2):168-171. doi: 10.3969/j.issn.1004-583X.2024.02.014
[7]	Wang Y, Di Biase L, Horton RP, et al. Left atrial appendage studied by computed tomography to help planning for appendage closure device placement[J]. J Cardiovasc Electrophysiol, 2010, 21(9):973-982. doi: 10.1111/j.1540-8167.2010.01814.x.
[8]	Wang F, Zhu M, Wang X, et al. Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2018, 18(1):153. doi: 10.1186/s12872-018-0889-y.
[9]	吴金家, 莫善洪. 非瓣膜性心房颤动左心耳血栓形成的研究进展[J]. 基层医学论坛, 2024, 28(1):26-28.doi:10.19435/j.1672-1721.2024.01.008.
[10]	Du H, Bi K, Xu L, et al. Analysis of risk factors for thrombosis of the left atrium/left atrial appendage in patients with non-valvular atrial fibrillation[J]. Cardiovasc J Afr, 2021, 32(3):116-122. doi: 10.5830/CVJA-2019-071.
[11]	侯玲丽, 任建丽. 实时三维经食管超声心动图评估左心耳结构和功能的研究进展[J]. 临床超声医学杂志, 2021, 23(1):57-60.doi:10.16245/j.cnki.issn1008-6978.2021.01.018.
[12]	Wang X, Xu X, Wang W, et al. Risk factors associated with left atrial appendage thrombosis in patients with non-valvular atrial fibrillation by transesophageal echocardiography[J]. Int J Cardiovasc Imaging, 2023, 39(7):1263-1273. doi: 10.1007/s10554-023-02841-x. pmid: 37149503
[13]	Yamamoto T, Endo D, Matsushita S, et al. Evidence and challenges in left atrial appendage management[J]. Ann Thorac Cardiovasc Surg, 2022, 28(1):1-17. doi: 10.5761/atcs.ra.21-00040.
[14]	张磊, 陈琳, 富路. 脑利钠肽在心房颤动中的应用[J]. 心血管康复医学杂志, 2021, 30(6):742-746.
[15]	Inohara T, Kim S, Pieper K, et al. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation[J]. Heart, 2019, 105(5):370-377. doi: 10.1136/heartjnl-2018-313642. pmid: 30228248
[16]	杜鑫, 薛禹辰, 杨清. 超声心动图在心房颤动诊疗中的应用进展[J]. 中国医药, 2019, 14(9):1430-1433.
[17]	Wang G, Li G, Hu F, et al. Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2023, 23(1):180. doi: 10.1186/s12872-022-03033-6.
[18]	Qiao Y, Zhao Z, Cai X, et al. Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk[J]. Thromb J, 2023, 21(1):34. doi: 10.1186/s12959-023-00478-3. pmid: 36998006
[19]	Kamili K, Zheng T, Luo C, et al. Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc scores: A cross-sectional study[J]. Lipids Health Dis, 2024, 23(1):22. doi: 10.1186/s12944-023-01990-1.
[20]	Zhang Y, Yuan YQ. Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation[J]. Arq Bras Cardiol, 2021, 116(2):325-331. English, Portuguese. doi: 10.36660/abc.20190492. pmid: 33470330
[21]	Wai SH, Kyu K, Galupo MJ, et al. Assessment of left atrial appendage function by transthoracic pulsed Doppler echocardiography: Comparing against transesophageal interrogation and predicting echocardiographic risk factors for stroke[J]. Echocardiography, 2017, 34(10):1478-1485. doi: 10.1111/echo.13659. pmid: 28849595
[22]	Doukky R, Garcia-Sayan E, Gage H, et al. The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation[J]. Cardiovasc Ultrasound, 2014, 12:10. doi: 10.1186/1476-7120-12-10.
[23]	Uziębło-życzkowska B, Krzesiński P, Jurek A, et al. Left Ventricular ejection fraction is associated with the risk of thrombus in the left atrial appendage in patients with atrial fibrillation[J]. Cardiovasc Ther, 2020, 2020:3501749. doi: 10.1155/2020/3501749.
[24]	Wybraniec MT, Mizia-Szubryt M, Cichoń M, et al. Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter[J]. ESC Heart Fail, 2022, 9(6):4064-4076. doi: 10.1002/ehf2.14105. pmid: 36039813
[25]	Kaufmann D, Wabich E, Kapłon-Cie'slicka A, et al. Echocardiographic predictors of thrombus in left atrial appendage-The role of novel transthoracic parameters[J]. Front Cardiovasc Med, 2022, 9:1059111. doi: 10.3389/fcvm.2022.1059111.
[26]	Deng B, Nie R, Qiu Q, et al. 3D transesophageal echocardiography assists in evaluating the morphology, function, and presence of thrombi of left atrial appendage in patients with atrial fibrillation[J]. Ann Transl Med, 2021, 9(10):876. doi: 10.21037/atm-21-1981. pmid: 34164510
[27]	Chen L, Xu C, Chen W, et al. Left atrial appendage orifice area and morphology is closely associated with flow velocity in patients with nonvalvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2021, 21(1):442. doi: 10.1186/s12872-021-02242-9.
[28]	郭楚娴, 杨龙, 张敏, 等. 左心耳血流速度对非瓣膜性心房颤动患者左心耳血栓形成的预测价值评估[J]. 中国循环杂志, 2022, 37(8):831-835.
[29]	Chen L, Zinda A, Rossi N, et al. A new risk model of assessing left atrial appendage thrombus in patients with atrial fibrillation - Using multiple clinical and transesophageal echocardiography parameters[J]. Int J Cardiol, 2020, 314:60-63. doi: 10.1016/j.ijcard.2020.04.039. pmid: 32305560
[30]	Yosefy C, Pery M, Nevzorov R, et al. Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation[J]. Clin Cardiol, 2020, 43(1):71-77. doi: 10.1002/clc.23292. pmid: 31755572
[31]	He Y, Chen P, Zhu Z, et al. Left atrial appendage depth and tachycardia bradycardia syndrome as important predictors of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation[J]. Comput Math Methods Med, 2022, 2022:4632823. doi: 10.1155/2022/4632823.
[32]	Castellani C, Gao Y, Kim H, et al. Left atrial appendage structural characteristics predict thrombus formation[J]. J Cardiovasc Electrophysiol, 2023, 34(8):1683-1689. doi: 10.1111/jce.15994.
[33]	黄晓华, 陈玉香, 谢超贤, 等. CTA定量评价广西壮族人群非瓣膜性房颤患者左心耳结构与血栓形成关联性及意义[J]. 中国CT和MRI杂志, 2023, 21(8):75-78.
[34]	Mill J, Harrison J, Saiz-Vivo M, et al. The role of the pulmonary veins on left atrial flow patterns and thrombus formation[J]. Sci Rep, 2024, 14(1):5860. doi: 10.1038/s41598-024-56658-2. pmid: 38467726
[35]	Fang R, Li Y, Zhang Y, et al. Impact of left atrial appendage location on risk of thrombus formation in patients with atrial fibrillation[J]. Biomech Model Mechanobiol, 2021, 20(4):1431-1443. doi: 10.1007/s10237-021-01454-4.
[36]	Nako S, Seo C, Tsutsui S, et al. Predicting intracardiac thrombus formation in the left atrial appendage using machine learning and CT images[J]. Annu Int Conf IEEE Eng Med Biol Soc, 2023, 2023:1-5. doi: 10.1109/EMBC40787.2023.10340345. pmid: 38082730
[37]	Jing M, Xi H, Li J, et al. Left atrial appendage thrombus is associated with a higher fractal dimension in patients with atrial fibrillation[J]. Clin Imaging, 2024, 114:110247. doi: 10.1016/j.clinimag.2024.110247.
[38]	Alinezhad L, Ghalichi F, Ahmadlouydarab M, et al. Left atrial appendage shape impacts on the left atrial flow hemodynamics: A numerical hypothesis generating study on two cases[J]. Comput Methods Programs Biomed, 2022, 213:106506. doi: 10.1016/j.cmpb.2021.106506.
[39]	Zhou X, Wang Z, Dou S, et al. Biomarkers for predicting left atrial or left atrial appendage thrombus in anticoagulated patients with nonvalvular atrial fibrillation[J]. Cardiol Res Pract, 2020, 2020:1683142. doi: 10.1155/2020/1683142.
[40]	Sun S, Su B, Lin J, et al. A nomogram to predict left atrial appendage thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients[J]. BMC Cardiovasc Disord, 2022, 22(1):311. doi: 10.1186/s12872-022-02737-z.
[41]	Akamatsu K, Ito T, Ozeki M, et al. Left atrial spontaneous echo contrast occurring in patients with low CHADS2 or CHA2DS2-VASc scores[J]. Cardiovasc Ultrasound, 2020, 18(1):31. doi: 10.1186/s12947-020-00213-2.
[42]	Harada M, Tabako S, Fujii Y, et al. Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function[J]. J Echocardiogr, 2018, 16(2):72-80. doi: 10.1007/s12574-017-0362-4. pmid: 29256043
[43]	Hautmann M, Zacher M, Fuchs S, et al. Left atrial appendage thrombus formation, potential of resolution and association with prognosis in a large real-world cohort[J]. Sci Rep, 2023, 13(1):889. doi: 10.1038/s41598-023-27622-3. pmid: 36650206
[44]	Lim HS, Willoughby SR, Schultz C, et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: Impact of rate and rhythm[J]. J Am Coll Cardiol, 2013, 61(8):852-860. doi: 10.1016/j.jacc.2012.11.046. pmid: 23333141
[45]	Deng Y, Zhou F, Li Q, et al. Associations between neutrophil-lymphocyte ratio and monocyte to high-density lipoprotein ratio with left atrial spontaneous echo contrast or thrombus in patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2023, 23(1):234. doi: 10.1186/s12872-023-03270-3.
[46]	何长健, 张艳, 马建帅, 等. 中性粒细胞/淋巴细胞比值与非瓣膜性心房颤动患者左心耳血栓状态的相关性[J]. 中国循环杂志, 2021, 36(9):891-896.
[47]	Koca F, Levent F, Sensoy B, et al. The predictive value of the systemic immune-inflammatory index for left atrial appendage thrombus in non-valvular atrial fibrillation[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2023, 167(2):162-168. doi: 10.5507/bp.2023.007. pmid: 36756877
[48]	Yao Y, Shang MS, Gao LJ, et al. Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score[J]. Europace, 2018, 20(7):1093-1098. doi: 10.1093/europace/eux189. pmid: 28637244
[49]	薛倩, 卓小桢, 杨春, 等. 基于列线图构建非瓣膜性房颤患者的左心耳血栓状态预测模型[J]. 分子影像学杂志, 2021, 44(2):232-238.
[50]	Goel R, Josephson CD, Patel EU, et al. Perioperative transfusions and venous thromboembolism[J]. Pediatrics, 2020, 145(4):e20192351. doi: 10.1542/peds.2019-2351.
[51]	赵曌, 王文强, 赵春慧, 等. 血小板形态参数、左心耳血流动力学参数与老年非瓣膜性心房颤动患者左心耳血栓形成的关系研究[J]. 实用心脑肺血管病杂志, 2022, 30(3):22-27.
[52]	Song J, Zhang X, Wei M, et al. Association between lipoprotein(a) and thromboembolism in patients with non-valvular atrial fibrillation: A cross-sectional study[J]. Lipids Health Dis, 2022, 21(1):78. doi: 10.1186/s12944-022-01682-2. pmid: 36002888
[53]	Meng W, Wang L, Fan H, et al. Total bilirubin level is associated with the risk of left atrial appendage thrombosis in patients with non-valvular atrial fibrillation[J]. Glob Heart, 2022, 17(1):90. doi: 10.5334/gh.1177. pmid: 36578911
[54]	Kapłon-Cie'slicka A, Budnik M, Gawałko M, et al. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus[J]. Heart, 2019, 105(17):1310-1315. doi: 10.1136/heartjnl-2018-314492. pmid: 31040170
[55]	Wang A, Green JB, Halperin JL, et al. Atrial fibrillation and diabetes mellitus: JACC review topic of the week[J]. J Am Coll Cardiol, 2019, 74(8):1107-1115. doi: 10.1016/j.jacc.2019.07.020. pmid: 31439220

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 55

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2025, 40(12): 1119-1123.
[2]	. [J]. Clinical Focus, 2025, 40(11): 1043-1046.
[3]	Liu Sanlong, Zhang Wenlong, Liu Ying, Du Guifang, Meng Zhaobin. Correlation analysis of S-Tp and S-Te intervals with heart failure with recovered ejection fraction [J]. Clinical Focus, 2025, 40(10): 893-896.
[4]	Liu Zhenliang, Zhou Yangjie, Wen Wei, Li Wanneng, Xi Binwu, Zhao Xu, Liu Qifang. Mapping and ablation on the non-coronary cusp for treating para-Hisian premature atrial contractions and atrial tachycardia [J]. Clinical Focus, 2025, 40(10): 904-909.
[5]	. [J]. Clinical Focus, 2025, 40(9): 850-854.
[6]	Cao Lihui, Huo Xianghui. Clinical diagnostic value of NT-proBNP and triglyceride-glucose index combined ith echocardiographic parameters in elderly patients with heart failure [J]. Clinical Focus, 2025, 40(6): 498-503.
[7]	Liu Jia, Yang Fengyu, Guo Mengya, Wu Zhuowei, Zhang Hanwen, Wang Yixuan, Chen Chunhong, Zhang Fang. The safety and efficacy of low-dose rivaroxaban in elderly patients with renal insufficiency and non-valvular atrial fibrillation [J]. Clinical Focus, 2025, 40(6): 509-512.
[8]	. [J]. Clinical Focus, 2025, 40(6): 558-563.
[9]	. [J]. Clinical Focus, 2025, 40(6): 564-569.
[10]	Liu Shenghua. Correlation between serum uric acid levels and coronary artery calcification severity in patients with stable angina pectoris [J]. Clinical Focus, 2025, 40(3): 211-216.
[11]	. [J]. Clinical Focus, 2025, 40(3): 275-280.
[12]	Hu Songlin, Di Ya, Liu Canzhang, Yan Jie. Study on the relationship between platelet/lymphocyte ratio and coronary plaque characteristics in coronary heart disease patients combined with type 2 diabetes mellitus by virtual histology intravascular ultrasound [J]. Clinical Focus, 2025, 40(2): 117-121.
[13]	. [J]. Clinical Focus, 2025, 40(2): 172-179.
[14]	. [J]. Clinical Focus, 2025, 40(2): 180-184.
[15]	Wang Ting, Chai Chunyan. Application of vericiguat in elderly patients with heart failure with reduced ejection fraction [J]. Clinical Focus, 2024, 39(12): 1081-1084.